StockData
Lyell Immunopharma, Inc. logo

Lyell Immunopharma, Inc. (LYEL) stock

LYELNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$13.67−0.98 (-6.69%)

Close on Nov 17, 2026Market cap $334.99MP/E –Yield –

Lyell Immunopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Lyell Immunopharma's price to book ratio was 1.7× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.3× to 2.1×, with a median of 1.0×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×−0.1
2025Dec 31, 20251.8×+1.5
2024Dec 31, 20240.3×−0.4
2023Dec 29, 20230.7×−0.4
2022Dec 30, 20221.1×−0.8
2021Dec 31, 20211.9×–

More Lyell Immunopharma figures

See a number that looks wrong?